ZBED5
geneOn this page
Also known as Buster1
Summary
ZBED5 (zinc finger BED-type containing 5, HGNC:30803) is a protein-coding gene on chromosome 11p15.4, encoding Zinc finger BED domain-containing protein 5 (Q49AG3).
This gene is unusual in that its coding sequence is mostly derived from Charlie-like DNA transposon; however, it does not appear to be an active DNA transposon as it is not flanked by terminal inverted repeats. The encoded protein is conserved among the mammalian Laurasiatheria branch. Multiple alternatively spliced variants, encoding the same protein, have been identified.
Source: NCBI Gene 58486 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 76 total
- MANE Select transcript:
NM_001143667
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30803 |
| Approved symbol | ZBED5 |
| Name | zinc finger BED-type containing 5 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Buster1 |
| Ensembl gene | ENSG00000236287 |
| Ensembl biotype | protein_coding |
| OMIM | 615251 |
| Entrez | 58486 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 15 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000413761, ENST00000432999, ENST00000525350, ENST00000526020, ENST00000526852, ENST00000528289, ENST00000530570, ENST00000533903, ENST00000533925, ENST00000534690, ENST00000876894, ENST00000876895, ENST00000876896, ENST00000876897, ENST00000931256, ENST00000931257, ENST00000931258, ENST00000931259, ENST00000931260
RefSeq mRNA: 2 — MANE Select: NM_001143667
NM_001143667, NM_021211
Canonical transcript exons
ENST00000413761 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001695798 | 10856144 | 10856257 |
| ENSE00001803103 | 10852706 | 10855086 |
| ENSE00002201728 | 10857862 | 10858053 |
Expression profiles
Bgee: expression breadth ubiquitous, 287 present calls, max score 97.28.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 47.6389 / max 468.4669, expressed in 1816 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 118665 | 32.9954 | 1811 |
| 118664 | 14.3471 | 1764 |
| 118663 | 0.2965 | 123 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibia | UBERON:0000979 | 97.28 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 97.19 | gold quality |
| ganglionic eminence | UBERON:0004023 | 96.86 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 96.83 | gold quality |
| hair follicle | UBERON:0002073 | 96.58 | gold quality |
| left ovary | UBERON:0002119 | 96.31 | gold quality |
| upper leg skin | UBERON:0004262 | 96.27 | gold quality |
| body of uterus | UBERON:0009853 | 96.21 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 96.03 | gold quality |
| ventricular zone | UBERON:0003053 | 95.95 | gold quality |
| right ovary | UBERON:0002118 | 95.92 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.89 | gold quality |
| skin of hip | UBERON:0001554 | 95.70 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 95.68 | gold quality |
| lymph node | UBERON:0000029 | 95.67 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 95.65 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.64 | gold quality |
| visceral pleura | UBERON:0002401 | 95.49 | gold quality |
| ovary | UBERON:0000992 | 95.47 | gold quality |
| thyroid gland | UBERON:0002046 | 95.46 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.34 | gold quality |
| right uterine tube | UBERON:0001302 | 95.34 | gold quality |
| cortical plate | UBERON:0005343 | 95.27 | gold quality |
| endocervix | UBERON:0000458 | 95.15 | gold quality |
| vermiform appendix | UBERON:0001154 | 95.15 | gold quality |
| endometrium | UBERON:0001295 | 95.10 | gold quality |
| calcaneal tendon | UBERON:0003701 | 95.09 | gold quality |
| rectum | UBERON:0001052 | 95.06 | gold quality |
| parietal pleura | UBERON:0002400 | 95.04 | gold quality |
| embryo | UBERON:0000922 | 95.01 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.57 |
| E-MTAB-6386 | no | 601.56 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2602.1 | ZBED5 | BED zinc finger factors |
JASPAR matrix evidence (PMIDs): PMID:39605368
miRNA regulators (miRDB)
11 targeting ZBED5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-487A-5P | 98.85 | 69.37 | 993 |
| HSA-MIR-487B-5P | 98.85 | 69.48 | 987 |
| HSA-MIR-605-5P | 98.79 | 68.24 | 1161 |
| HSA-MIR-548AO-5P | 98.55 | 69.57 | 1362 |
| HSA-MIR-548AX | 98.55 | 69.58 | 1362 |
| HSA-MIR-1248 | 98.47 | 67.54 | 1314 |
| HSA-MIR-3614-3P | 97.81 | 67.15 | 582 |
| HSA-MIR-424-3P | 97.20 | 65.86 | 385 |
| HSA-MIR-600 | 97.07 | 66.73 | 1259 |
Cross-species orthologs
0 orthologs
Paralogs (18): GTF2IRD1 (ENSG00000006704), ZMYM2 (ENSG00000121741), ZMYM5 (ENSG00000132950), THAP12 (ENSG00000137492), ZMYM4 (ENSG00000146463), ZMYM3 (ENSG00000147130), ZMYM6 (ENSG00000163867), KIAA1958 (ENSG00000165185), GTF2IRD2B (ENSG00000174428), EPM2AIP1 (ENSG00000178567), GTF2IRD2 (ENSG00000196275), ZMYM1 (ENSG00000197056), QRICH1 (ENSG00000198218), FAM200C (ENSG00000221886), FAM200A (ENSG00000221909), SCAND3 (ENSG00000232040), FAM200B (ENSG00000237765), GTF2I (ENSG00000263001)
Protein
Protein identifiers
Zinc finger BED domain-containing protein 5 — Q49AG3 (reviewed: Q49AG3)
Alternative names: Transposon-derived Buster1 transposase-like protein
All UniProt accessions (5): Q49AG3, E9PJ57, E9PJT5, E9PM71, E9PNT1
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. May be derived from an ancient transposon that has lost its ability to translocate.
RefSeq proteins (2): NP_001137139, NP_067034 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003656 | Znf_BED | Domain |
| IPR012337 | RNaseH-like_sf | Homologous_superfamily |
Pfam: PF02892
UniProt features (10 total): binding site 4, sequence variant 4, chain 1, zinc finger region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q49AG3-F1 | 81.57 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 132; 135; 152; 157
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 134 (showing top):
MODULE_493, GGGTGGRR_PAX4_03, DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN, SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP, TAANNYSGCG_UNKNOWN, EVI1_04, MODULE_332, MARSON_BOUND_BY_FOXP3_STIMULATED, GCGSCMNTTT_UNKNOWN, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, KIM_WT1_TARGETS_DN, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP, PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN, HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN, WHITFIELD_CELL_CYCLE_S
GO Biological Process (0):
GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
474 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBED5 | ZBED10P | Q96FA7 | 571 |
| ZBED5 | TMPRSS11D | O60235 | 479 |
| ZBED5 | MAGEB17 | A8MXT2 | 478 |
| ZBED5 | ZBED6 | P86452 | 447 |
| ZBED5 | TTC23L | Q6PF05 | 447 |
| ZBED5 | ZSCAN30 | Q86W11 | 431 |
| ZBED5 | ZNF850 | A8MQ14 | 420 |
| ZBED5 | NUDT8 | Q8WV74 | 419 |
| ZBED5 | ZNF235 | Q14590 | 418 |
| ZBED5 | TMEM177 | Q53S58 | 396 |
| ZBED5 | ZBED2 | Q9BTP6 | 393 |
| ZBED5 | RNF175 | Q8N4F7 | 393 |
| ZBED5 | ZNF770 | Q6IQ21 | 393 |
| ZBED5 | C6orf136 | Q5SQH8 | 391 |
| ZBED5 | ZBED4 | O75132 | 373 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZBED5 | AMIGO1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZBED5 | SMAD4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| FGFR3 | U2SURP | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2A | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2B | MMP24OS | psi-mi:“MI:0914”(association) | 0.350 |
| ZBED5 | sdhA | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZBED5 | tkt1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZBED5 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| ZBED5 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| ERG | ZBED5 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): ZBED5 (Affinity Capture-MS), ZBED5 (Affinity Capture-MS), ZBED5 (Proximity Label-MS), AMIGO1 (Affinity Capture-MS), ZBED5 (Two-hybrid), ZBED5 (Affinity Capture-MS), ZBED5 (Affinity Capture-MS), ZBED5 (Affinity Capture-MS), ZBED5 (Affinity Capture-RNA), ZBED5 (Two-hybrid)
ESM2 similar proteins: A3KMX0, A4IFA3, A4IGY9, A4Z943, A4Z944, B8QB46, D2EAC2, E1C2V1, O43422, O60290, P10911, P35125, P86452, Q13075, Q2NKX8, Q3UPF5, Q49AG3, Q5FWF4, Q5SVZ6, Q5T890, Q5TKR9, Q6DJS0, Q6EKJ0, Q6R2W3, Q6YI93, Q7Z2W4, Q80WE4, Q86UP8, Q86VD1, Q8BZ21, Q8N8K9, Q8QMP8, Q8TDB6, Q8WML3, Q92794, Q96JM7, Q96JS3, Q99388, Q99NI3, Q9CUX1
Diamond homologs: A4Z943, A4Z944, A4Z945, O95789, P0CF97, Q49AG3, Q4R6P1, Q6R2W3, Q8IZ13, Q8TCP9, A2A791, A6QPH9, Q14202, Q3U2E2, Q4R3D6, Q5RDJ2, Q5SVZ6, Q5VZL5, Q9CU65, Q9JLM4, Q9UBW7, Q9UJ78, P17029, Q4KLI1, Q5R670, Q8BGS3, A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
76 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 72 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
981 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:10857988:G:C | donor_gain | 1.0000 |
| 11:10854852:T:C | acceptor_gain | 0.9900 |
| 11:10854852:T:TC | acceptor_gain | 0.9900 |
| 11:10855088:T:C | acceptor_gain | 0.9900 |
| 11:10855106:A:C | acceptor_gain | 0.9900 |
| 11:10854846:A:AC | acceptor_gain | 0.9800 |
| 11:10855099:T:TC | acceptor_gain | 0.9800 |
| 11:10855103:C:CT | acceptor_gain | 0.9800 |
| 11:10857082:T:TA | donor_gain | 0.9800 |
| 11:10857683:CCAA:C | donor_gain | 0.9800 |
| 11:10857684:CAAC:C | donor_gain | 0.9800 |
| 11:10857685:AACA:A | donor_gain | 0.9800 |
| 11:10857040:AAAGC:A | donor_gain | 0.9700 |
| 11:10857985:T:A | donor_gain | 0.9700 |
| 11:10854845:A:T | acceptor_gain | 0.9600 |
| 11:10855082:CTTTT:C | acceptor_gain | 0.9600 |
| 11:10857300:C:CA | donor_gain | 0.9600 |
| 11:10854844:CAA:C | acceptor_gain | 0.9500 |
| 11:10855087:C:CC | acceptor_gain | 0.9500 |
| 11:10858005:AGG:A | donor_gain | 0.9500 |
| 11:10854838:C:CT | acceptor_gain | 0.9400 |
| 11:10854838:C:T | acceptor_gain | 0.9400 |
| 11:10854911:T:TC | acceptor_gain | 0.9400 |
| 11:10855119:C:CC | acceptor_gain | 0.9400 |
| 11:10856256:GCC:G | acceptor_loss | 0.9400 |
| 11:10856257:CCTAG:C | acceptor_loss | 0.9400 |
| 11:10856258:CTAG:C | acceptor_loss | 0.9400 |
| 11:10856259:T:G | acceptor_loss | 0.9400 |
| 11:10857659:G:GT | donor_gain | 0.9400 |
| 11:10855105:C:CT | acceptor_gain | 0.9300 |
AlphaMissense
4572 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:10854589:A:C | F119L | 0.996 |
| 11:10854589:A:T | F119L | 0.996 |
| 11:10854591:A:G | F119L | 0.996 |
| 11:10854590:A:G | F119S | 0.988 |
| 11:10854445:A:C | F167L | 0.983 |
| 11:10854445:A:T | F167L | 0.983 |
| 11:10854447:A:G | F167L | 0.983 |
| 11:10854497:C:G | R150P | 0.980 |
| 11:10854442:G:C | F168L | 0.978 |
| 11:10854442:G:T | F168L | 0.978 |
| 11:10854444:A:G | F168L | 0.978 |
| 11:10854490:A:C | H152Q | 0.977 |
| 11:10854490:A:T | H152Q | 0.977 |
| 11:10853032:A:C | F638L | 0.976 |
| 11:10853032:A:T | F638L | 0.976 |
| 11:10853034:A:G | F638L | 0.976 |
| 11:10854360:C:G | A196P | 0.975 |
| 11:10854593:C:T | G118E | 0.975 |
| 11:10853098:A:C | F616L | 0.974 |
| 11:10853098:A:T | F616L | 0.974 |
| 11:10853100:A:G | F616L | 0.974 |
| 11:10854224:A:T | V241E | 0.972 |
| 11:10854127:A:C | F273L | 0.971 |
| 11:10854127:A:T | F273L | 0.971 |
| 11:10854129:A:G | F273L | 0.971 |
| 11:10853212:A:C | F578L | 0.970 |
| 11:10853212:A:T | F578L | 0.970 |
| 11:10853214:A:G | F578L | 0.970 |
| 11:10854197:C:G | R250P | 0.968 |
| 11:10854282:C:G | A222P | 0.967 |
dbSNP variants (sampled 300 via entrez): RS1000210877 (11:10852625 C>T), RS1000595629 (11:10858274 G>C), RS1000718328 (11:10852422 A>C), RS1000967628 (11:10858456 G>A), RS1001709153 (11:10858878 A>G), RS1001878211 (11:10852531 G>C), RS1002138066 (11:10857394 G>T), RS1002138935 (11:10858736 C>T), RS1002320563 (11:10858281 T>G), RS1002584755 (11:10855898 T>A), RS1002963861 (11:10856315 G>A), RS1003087984 (11:10856219 A>C), RS1003549977 (11:10855983 A>G), RS1003558771 (11:10854718 T>C), RS1003577252 (11:10859983 C>T)
Disease associations
OMIM: gene MIM:615251 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003820_3 | Knee osteoarthritis | 6.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs10840501 | ZBED5 | 0.00 | 0 |
CTD chemical–gene interactions
38 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 3 |
| sodium arsenite | decreases expression, affects cotreatment, increases abundance | 2 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| FR900359 | decreases phosphorylation | 1 |
| TAK-243 | increases sumoylation | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| trichostatin A | affects expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| jinfukang | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Vehicle Emissions | increases abundance, increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Manganese | decreases expression, increases abundance, affects cotreatment | 1 |
| Naled | affects expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Quercetin | decreases expression | 1 |
| Silver | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): osteoarthritis, knee